24 November 2004
Contents:
- USFTA finalised but US to act to delay generic medicines
- Minister warns on deal with Beijing
- Trade deal with China on agenda in PM's visit
- Reminder: AFTINET seminar on China FTA: Sydney 7 December
1. USFTA finalised but US may take action to delay generic
medicines: AFTINETs response
Below is an article revealing that the US has signed off on the FTA legislation but
drug companies and the US government want to use the USFTA dispute process to challenge
the amendment intended to prevent big drug companies from delaying access to generic
drugs. AFTINET s media release in response is also below. We were interviewed on the
ABC Radio National AM program on November 24 and had letters published in
the Sydney Morning Herald and the Australian Financial Review on
November 20 and 22.
US wins legal pledge on generic drugs
By Lenore Taylor, 23/11/2004 Australian Financial Review
The United States pharmaceutical industry says the Howard government has promised that
US drug companies will be able to take legal action to keep some generic medicines out of
Australia as part of the deal to clinch a US free-trade agreement.
"We appreciate that US negotiators sought and received a clarification by
Australia that patent-holders will be assured of adequate opportunity to seek injunctive
relief against patent infringers, before infringing products are put on the market in
Australia, as required by the agreement," the Pharmaceutical Research and
Manufacturers of America said in a statement. PhRMA lobbied intensively after the
Australian election against Labor's pre-election amendments to the free-trade agreement.
Labor's amendments aimed to stop drug manufacturers abusing the patent system by taking
legal action to lock out cheaper generic drugs.
The federal government refused to repeal the amendments, but said it would make minor
modifications to Australia's US-FTA law during the final two weeks of parliamentary
sittings this year.
The US government said it had "agreed to disagree" with Australia on the drug
patent issue. It said it would watch how the Australian law was implemented then take
action bilaterally, or in the World Trade Organisation, if it believed US drug
manufacturers were being dealt with unfairly by the Australian laws.
According to PhRMA, the US government told Australia that Labor's FTA amendments were
"unjustifiable, counter-productive and violate Australia's international
obligations".
PhRMA said it was "disappointed that the Australian government, which expressed
concern with these very amendments when they were introduced, is not taking immediate
action to repeal them".
It said the amendments could also "undermine advanced biomedical research and life
sciences investments in Australia".
The FTA is due to come into effect by January 1. Under the Labor amendments, drug
companies face penalties of up to $10 million for "vexatious or unreasonably
pursued" patent protection claims
AFTINET media release: Public Interest Groups condemn drug industry call to use
USFTA to lock out cheaper medicines
"US drug companies claims that the USFTA gives them the right to take legal
action to delay Australians access to cheaper generic medicines are unacceptable and
confirm the fears of community groups about rising costs for medicines," said Dr
Patricia Ranald, Principal Policy Officer with the Public Interest Advocacy Centre and
Convenor of the Australian Fair Trade and Investment Network of 90 community organisations
(AFTINET).
The US Pharmaceutical Research and Manufacturers of America (quoted today in the
Australian Financial Review p.4) condemned the ALP amendments to the USFTA implementing
legislation passed by the Australian Parliament, and expressed disappointment that the
Australian government is not immediately seeking to repeal them. The amendments seek to
prevent big drug companies from using legal tactics to delay access to cheaper generic
medicines.
This follows the widely reported US government statement last week that it would not
demand immediate repeal of the amendments but would lodge a dispute to challenge the ALP
amendment after the USFTA is implemented next January.
"The US government will have the right to challenge the amendment, have the
dispute heard under trade rules, and get a ruling against the amendment, backed up by
trade sanctions, " explained Dr Ranald. "Such a ruling would be possible because
the USFTA principles protect the patent rights of drug companies, not the rights of
consumers. This undermines the Australian Parliaments democratic right to decide
medicines policy and will lead to higher prices for medicines."
Top of page
2. Minister warns on deal with Beijing
Steve Lewis and Katharine Murphy, The Australian, November 24, 2004
A FREE trade deal with China was both an opportunity and a "threat" for
Australian manufacturers, federal Industry Minister Ian Macfarlane has warned.
As John Howard hailed "quite good progress" towards a trade deal with China,
Mr Macfarlane said yesterday the manufacturing sector faced its biggest challenge since
the tariff reforms of the mid-1980s to avoid cheap imports swamping the domestic market.
"We do need to get cautiously onto the front foot and position ourselves for a long
term market interaction with China," he said.
Mr Macfarlane has assured industry he would stand up for its interests in cabinet --
even if that made him unpopular among more zealous ministers. His comments reflect a
vigorous debate emerging within the Government about whether China's economy and laws were
up to the standard demanded of a modern market economy.
"Whilst it's a great opportunity for the rest of my portfolio -- Tourism and
Resources -- I'm just a little wary of any price that industry would be expected to
pay," Mr Macfarlane told The Australian.
The minister's remarks on a trade deal with Beijing come as business has also raised
concerns that China has lax laws on issues such as copyright, dumping and legal protection
of contracts. "If an FTA is going to deliver free access for Australian industry to
that market, those issues have to be on the table," said Australian Industry Group
chief Heather Ridout.
Australia's trade deficit with China has ballooned in recent years, reaching $5 billion
last year -- up sharply from $2.5 billion in 1999. China's cheap labour costs have seen a
flood of clothing and other manufactured goods imported into Australia, a trend that would
only accelerate under an FTA. But the links were already so advanced that Australia's
economy relied heavily on Chinese manufactures.
About 70 per cent of Australian clothing, for example, or $2 billion of imports are
made in China -- more than double our total wool exports to the world. An acid test for
cabinet will be when ministers consider whether to grant China's high-growth economy
"market status" -- a precondition for any FTA.
This would allow China to bypass many of the anti-dumping rules, which exist to prevent
developing economies from undercutting Australia's domestic manufacturers.
Mr Macfarlane is determined that the interests of Australian manufacturing are not
trampled in a rush by the Government to conclude an FTA. "China at some stage will be
able to demonstrate itself as a market economy but that should be done and assessed on the
basis of due process -- it shouldn't be politicised or short cut because of political
expediency."
Mr Macfarlane also hopes Australian firms see the deal to push further reforms in the
way that tariff cuts drove marked improvements in efficiency and competitiveness. "If
we don't get it right, then industry will be the loser, and that is the challenge and that
is why we have to be cautiously on the front foot," he said.
The Prime Minister emerged from talks with Chinese President Hu Jintao during the APEC
summit in Chile with an upbeat message on the progress of preliminary FTA talks. "It
is agreed by both sides that we are making good progress and that we have a fantastic
economic relationship that has just burgeoned unbelievably over the last few years,"
Mr Howard said.
Mr Macfarlane also believes a bilateral pact is likely. "I think we are seeing the
possibility of an (FTA) with China in three to four years -- we just need to ensure that
all due process is taken."
Top of page
3. Trade deal with China on agenda in PM's visit
By Tom Allard, Foreign Affairs Reporter in Santiago and agencies, Sydney Morning
Herald, November 23, 2004
Australia is likely to begin formal negotiations towards a free trade pact with China
in April, when the Prime Minister plans to visit the country.
John Howard met the Chinese President, Hu Jintao, on Sunday as the Asia-Pacific
Economic Co-operation forum concluded, with leaders optimistic of continued strong
economic growth in the region and successful World Trade Organisation talks next year.
Leaders from the 21 Pacific rim economies also endorsed a drive against corruption, and
issued a statement condemning terrorism and supporting efforts to curtail weapons of mass
destruction.
After meeting Mr Hu, Mr Howard said both leaders had agreed that a study into a free
trade agreement was progressing, despite the sensitivities. Australian manufacturers and
Chinese farmers could lose under a free trade agreement, but benefits to Australia are
potentially huge.
Mr Howard said: "It's agreed by both sides that we are making progress." He
said he would visit China in April for the Bao Economic Forum, China's version of the
World Economic Forum in Davos, Switzerland. He will also meet Chinese leaders.
Officials described their talks as congenial, with Mr Howard advocating more contracts
for Australian liquefied natural gas producers and discuss the nuclear stand-off on the
Korean peninsula.
The two leaders met after the second APEC leaders' retreat had finished. Mr Howard said
it had been the best APEC meeting for a number of years.
"There's a sense that the momentum has been regained. The meeting is taking place
at a time when the world economy is at its best for around 27 years," he said. _
Australian officials had started talks with China to explore the possibility of uranium
exports, the Federal Government said last night.
The Australian mining company WMC Resources asked the Government to pursue the
possibility of an export deal, which would require China to commit to Australian laws that
the product not be used for military purposes.
Top of page
4. AFTINET Sydney Seminar on China FTA: 7 December
A China-Australia Free Trade Agreement: What about human rights?
A seminar organised by the Australian Fair Trade and Investment Network (AFTINET),
the Public Interest Advocacy Centre (PIAC) and the Australian Manufacturing
Workers Union (AMWU).
The Australian and Chinese Governments are discussing a possible Free Trade Agreement.
China is one of the fastest growing economies in the world and is already Australias
second largest trading partner. But the lack of basic workplace and human rights mean many
Chinese people are not sharing the benefits of economic growth. In Australia, complete
removal of tariffs could mean higher unemployment at a time when workplace rights are also
being reduced. Both governments are considering only economic impacts. This seminar
examines the social and human rights impacts in both countries.
With:
- Dr Patricia Ranald, Public Interest Advocacy Centre and AFTINET (Chair)
- Doug Cameron, National Secretary, AMWU
- Sean Cooney, Senior Lecturer in Law, University of Melbourne
Tuesday 7 December, 12pm-2pm
Jubilee Room, NSW Parliament House, Macquarie Street, Sydney
Light lunch supplied
RSVP to Katharine Slattery, AFTINET, Phone (02) 9299 7833 or email kslattery@piac.asn.au